TrialTrials2017

A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial.

Hideo Saka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.